Adrian Thomas is global head of health economics and market accessfor the pharmaceutical and medical device businesses of Johnson & Johnson, where he is alsoa vice presidentleading access and public health programming for the company. With a special interest in the fields of pricing, reimbursement, real-world evidence, public health, commercial strategy, and policy, Thomas has held senior roles in risk management and drug safety, medical affairs, drug development, and product management. He is a clinical pharmacologist and vascular physician with experience in clinical trials design and methodology. Thomas is a fellow of the Royal Australasian College of Physicians and the College of Medical Administrators.
Previously
![Bringing New Drugs to the World](https://aspenideasfestival.imgix.net/null8508ba3c-bdb9-4aad-b8b6-88511758799f/27799139492_c2c108527b_h.jpg?auto=compress%2Cformat&fit=min&fm=jpg&h=225&q=80&rect=0%2C0%2C1600%2C899&w=400)
Pharmaceutical advances are expanding, with some exciting new drugs already on the market and others ready to emerge from the pipeline. These therapeutics offer fresh hope fo...